ASCO Registry

This page was last updated on 3/9/2023. Please check back frequently for updates.

The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) collects data about patients undergoing cancer treatment who have a confirmed prior or current COVID-19 infection. Specifically, the registry collects data about patients with cancer and patients who are cancer-free receiving adjuvant cancer therapy within a year of cancer surgery, including patients receiving hormone-only adjuvant therapy and patients receiving supportive care only. The ASCO Registry is designed to collect both baseline and follow-up data on how the virus impacts cancer care and cancer patient outcomes during the COVID-19 pandemic and into 2022. The Registry is closed to new practices/patients; however, we are continuing to collect follow-up data on current patients.

ASCO provides deidentified ASCO Registry data for research purposes to qualified individuals and organizations. Information on the process to submit a proposed research study is available at the Data Library link below.


View the COVID-19 Data Dashboard    View the COVID-19 Registry Data Map   

Request the COVID-19 Registry Data in ASCO’s Data Library

Study Information

ASCO Publications

ASCO Research Grants

Grantee Publications

Please contact the CENTRA team for additional information or questions. NCT04659135